Nanion Technologies and InnoVitro

Munich, Germany, May 1st 2021: Assessing preclinical cardiac contractility without animal use, but with human iPSC-derived cardiomyocytes is not only attractive for people in the cardiac community!

Parliamentary State Secretary Thomas Rachel (representing the Federal Ministry of Education & Research) stopped by InnoVitro headquarters in Jülich to award them with a 200k grant for the support of the new project SMOOTH: “Semi–synthetic Muscle Organoids based On Tissue Hybrids”

Read the full press release in German here.